A prospective study of preferences and actual treatment choices in ALS
- PMID: 10430414
- DOI: 10.1212/wnl.53.2.278
A prospective study of preferences and actual treatment choices in ALS
Abstract
Objective: To determine whether ALS patients' preferences for ameliorative or life-extending technologies elicited early in the disease were related to later treatment choices.
Methods: In this prospective cohort study, 121 patients were seen at a tertiary ALS care center and followed for a median of 12 months. At baseline, patient preferences for use of tracheostomy and percutaneous endoscopic gastrostomy (PEG) placement were elicited. All patients received the same educational information before being interviewed about treatment preferences. Patients were then followed to determine if patients who viewed the interventions favorably at baseline were significantly more likely to use the interventions over follow-up.
Results: Six to twelve percent of patients were certain they wanted tracheostomy and 28.2% wanted PEG. Preferences were related to later treatment choices: 20% of patients who found tracheostomy acceptable had one in the follow-up period, compared with 3.4% of those not in favor (p < 0.001). For PEG, similar findings were obtained: 48.5% who initially found it acceptable had PEG, versus 8.1% of those not in favor of this treatment (p < 0.001). Patients who found the interventions acceptable were more likely to be recently diagnosed, expressed greater attachment to life, and showed greater declines in pulmonary function over follow-up.
Conclusions: Patients with ALS were able to express their preferences for life-extending or ameliorative technologies and made choices consistent with these preferences. However, patient preferences may change over time, and clinical education efforts are required throughout the course of disease.
Comment in
-
Patient choices in ALS: life-sustaining treatment versus palliative care?Neurology. 1999 Jul 22;53(2):248-9. doi: 10.1212/wnl.53.2.248. Neurology. 1999. PMID: 10430408 No abstract available.
Similar articles
-
Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study.Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):233-242. doi: 10.1080/21678421.2016.1270325. Epub 2017 Jan 11. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28076984
-
Predictors and course of elective long-term mechanical ventilation: A prospective study of ALS patients.Amyotroph Lateral Scler. 2006 Jun;7(2):86-95. doi: 10.1080/14660820500515021. Amyotroph Lateral Scler. 2006. PMID: 16753972
-
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival.J Neurol Sci. 2011 May 15;304(1-2):44-8. doi: 10.1016/j.jns.2011.02.016. Epub 2011 Mar 3. J Neurol Sci. 2011. PMID: 21371720
-
The ALSFRSr predicts survival time in an ALS clinic population.Neurology. 2005 Jan 11;64(1):38-43. doi: 10.1212/01.WNL.0000148648.38313.64. Neurology. 2005. PMID: 15642901
-
[The patient's opinion matters: experience in the nutritional care in an ALS multidisciplinary team].Nutr Hosp. 2015 May 7;31 Suppl 5:56-66. doi: 10.3305/nh.2015.31.sup5.9132. Nutr Hosp. 2015. PMID: 25938606 Review. Spanish.
Cited by
-
What influences patient decision-making in amyotrophic lateral sclerosis multidisciplinary care? A study of patient perspectives.Patient Prefer Adherence. 2012;6:829-38. doi: 10.2147/PPA.S37851. Epub 2012 Nov 27. Patient Prefer Adherence. 2012. PMID: 23226006 Free PMC article.
-
Outcome of ventilatory support for acute respiratory failure in motor neurone disease.J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):752-6. doi: 10.1136/jnnp.72.6.752. J Neurol Neurosurg Psychiatry. 2002. PMID: 12023419 Free PMC article.
-
Persisting misconceptions about patients' attitudes at the end of life.Support Care Cancer. 2005 Apr;13(4):203-5. doi: 10.1007/s00520-004-0754-7. Epub 2005 Jan 12. Support Care Cancer. 2005. PMID: 15645188 No abstract available.
-
What are cancer patients' preferences about treatment at the end of life, and who should start talking about it? A comparison with healthy people and medical staff.Support Care Cancer. 2005 Apr;13(4):206-14. doi: 10.1007/s00520-004-0725-z. Epub 2005 Jan 19. Support Care Cancer. 2005. PMID: 15657689
-
Medical and supportive care among people with ALS in the months before death or tracheostomy.J Pain Symptom Manage. 2009 Oct;38(4):546-53. doi: 10.1016/j.jpainsymman.2008.11.013. Epub 2009 Jun 18. J Pain Symptom Manage. 2009. PMID: 19540088 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous